Search

Bridget E. Bunner

Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1644, 1647
Total Applications
1463
Issued Applications
725
Pending Applications
157
Abandoned Applications
602

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12837340 [patent_doc_number] => 20180170953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/866669 [patent_app_country] => US [patent_app_date] => 2018-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866669 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/866669
Prototype systems of theranostic biomarkers for in vivo molecular management of cancer Jan 9, 2018 Issued
Array ( [id] => 15775501 [patent_doc_number] => 20200118768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => COMPOSITIONS AND METHODS OF MAKING METAL-ORGANIC FRAMEWORKS WITH REDOX-ACTIVE CENTERS [patent_app_type] => utility [patent_app_number] => 16/471812 [patent_app_country] => US [patent_app_date] => 2017-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471812 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471812
Compositions and methods of making metal-organic frameworks with redox-active centers Dec 28, 2017 Issued
Array ( [id] => 15086231 [patent_doc_number] => 20190337926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => BMP-SIGNAL-INHIBITING COMPOUND [patent_app_type] => utility [patent_app_number] => 16/473850 [patent_app_country] => US [patent_app_date] => 2017-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 705 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473850 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/473850
BMP-signal-inhibiting compound Dec 25, 2017 Issued
Array ( [id] => 13300107 [patent_doc_number] => 20180201590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS [patent_app_type] => utility [patent_app_number] => 15/848639 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848639 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/848639
Azocane and azonane derivatives and methods of treating hepatitis B infections Dec 19, 2017 Issued
Array ( [id] => 17036630 [patent_doc_number] => 20210253588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 16/471237 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471237 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471237
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment Dec 19, 2017 Issued
Array ( [id] => 16743258 [patent_doc_number] => 10968232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Antidiabetic spirochroman compounds [patent_app_type] => utility [patent_app_number] => 16/465156 [patent_app_country] => US [patent_app_date] => 2017-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 858 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465156 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/465156
Antidiabetic spirochroman compounds Dec 14, 2017 Issued
Array ( [id] => 16381927 [patent_doc_number] => 10806737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Compounds and methods for the targeted degradation of fetal liver kinase polypeptides [patent_app_type] => utility [patent_app_number] => 15/840950 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 69734 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 883 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840950 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/840950
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides Dec 12, 2017 Issued
Array ( [id] => 12641103 [patent_doc_number] => 20180105532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 15/841153 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841153 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/841153
HETEROCYCLIC COMPOUNDS AND THEIR USES Dec 12, 2017 Abandoned
Array ( [id] => 15813941 [patent_doc_number] => 10632127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Targeted notch pathway inhibitors [patent_app_type] => utility [patent_app_number] => 15/837199 [patent_app_country] => US [patent_app_date] => 2017-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 16097 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837199 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/837199
Targeted notch pathway inhibitors Dec 10, 2017 Issued
Array ( [id] => 17556031 [patent_doc_number] => 11312707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-26 [patent_title] => Compositions and methods for the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 16/464377 [patent_app_country] => US [patent_app_date] => 2017-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12396 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464377 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/464377
Compositions and methods for the treatment of fungal infections Nov 23, 2017 Issued
15/574097 ENHANCED ANTIBIOTIC COMPOSITION Nov 13, 2017 Abandoned
Array ( [id] => 16253857 [patent_doc_number] => 20200263231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => Fluorogenic dyes for high sensitivity DNA detection [patent_app_type] => utility [patent_app_number] => 16/340373 [patent_app_country] => US [patent_app_date] => 2017-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340373 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/340373
Fluorogenic dyes for high sensitivity DNA detection Oct 31, 2017 Abandoned
Array ( [id] => 14836129 [patent_doc_number] => 20190276465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => Nitrogen-Containing Heterocyclic Compounds As FXR Modulators [patent_app_type] => utility [patent_app_number] => 16/346807 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 345 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/346807
Nitrogen-containing heterocyclic compounds as FXR modulators Oct 26, 2017 Issued
Array ( [id] => 15227467 [patent_doc_number] => 10501443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Pyridone compound as c-met inhibitor [patent_app_type] => utility [patent_app_number] => 16/343387 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11126 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343387 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/343387
Pyridone compound as c-met inhibitor Oct 26, 2017 Issued
Array ( [id] => 15556669 [patent_doc_number] => 20200062746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => PROCESS FOR THE PREPARATION OF (3S,4S)-TETRAHYDROFURAN-3-YL 4-ISOPROPYL-6,7-DIHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-CARBOXYLATE [patent_app_type] => utility [patent_app_number] => 16/344608 [patent_app_country] => US [patent_app_date] => 2017-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4212 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344608 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/344608
Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylate Oct 24, 2017 Issued
Array ( [id] => 14682177 [patent_doc_number] => 20190240203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => NOVEL ANTIBIOTICS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/342903 [patent_app_country] => US [patent_app_date] => 2017-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22878 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342903 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/342903
Antibiotics and methods of using same Oct 19, 2017 Issued
Array ( [id] => 16665055 [patent_doc_number] => 10934286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Heterocyclic sulfones as ROR gamma modulators [patent_app_type] => utility [patent_app_number] => 16/341474 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27671 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341474 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341474
Heterocyclic sulfones as ROR gamma modulators Oct 11, 2017 Issued
Array ( [id] => 14864621 [patent_doc_number] => 20190282552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => Treatment of synucleinopathies [patent_app_type] => utility [patent_app_number] => 16/340929 [patent_app_country] => US [patent_app_date] => 2017-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/340929
Treatment of synucleinopathies Oct 9, 2017 Issued
Array ( [id] => 14993517 [patent_doc_number] => 20190315716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/341005 [patent_app_country] => US [patent_app_date] => 2017-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63030 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 749 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341005 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341005
Heteroaryl compounds and their use as Mer inhibitors Oct 8, 2017 Issued
Array ( [id] => 16832101 [patent_doc_number] => 11008342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Crystalline polymorphs of a muscarinic acetylcholine receptor agonist [patent_app_type] => utility [patent_app_number] => 16/338930 [patent_app_country] => US [patent_app_date] => 2017-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 23127 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338930 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/338930
Crystalline polymorphs of a muscarinic acetylcholine receptor agonist Oct 4, 2017 Issued
Menu